Total Payments
$232,058
2024 Payments
$273.52
Companies
20
Transactions
289
Medicare Patients
835
Medicare Billing
$102,993
Payment Breakdown by Category
Other$164,400 (70.8%)
Travel$42,205 (18.2%)
Consulting$20,401 (8.8%)
Food & Beverage$4,925 (2.1%)
Education$127.37 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $162,000 | 41 | 69.8% |
| Travel and Lodging | $42,205 | 152 | 18.2% |
| Consulting Fee | $20,401 | 4 | 8.8% |
| Food and Beverage | $4,925 | 83 | 2.1% |
| Honoraria | $2,400 | 1 | 1.0% |
| Education | $127.37 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $220,020 | 241 | $0 (2024) |
| ARGENX US, INC. | $6,454 | 11 | $0 (2022) |
| GENZYME CORPORATION | $2,497 | 2 | $0 (2022) |
| Pharmacosmos Therapeutics Inc. | $2,400 | 1 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $150.95 | 4 | $0 (2024) |
| PFIZER INC. | $102.64 | 6 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $82.71 | 3 | $0 (2024) |
| Incyte Corporation | $70.30 | 4 | $0 (2017) |
| SOBI, INC | $35.93 | 2 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $32.88 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $273.52 | 9 | Alexion Pharmaceuticals, Inc. ($135.81) |
| 2023 | $22.24 | 1 | AstraZeneca Pharmaceuticals LP ($22.24) |
| 2022 | $8,992 | 15 | ARGENX US, INC. ($6,454) |
| 2021 | $77.92 | 4 | Daiichi Sankyo Inc. ($48.87) |
| 2020 | $2,424 | 2 | Pharmacosmos Therapeutics Inc. ($2,400) |
| 2019 | $16,554 | 14 | Daiichi Sankyo Inc. ($16,526) |
| 2018 | $101,784 | 105 | Daiichi Sankyo Inc. ($101,675) |
| 2017 | $101,930 | 139 | Daiichi Sankyo Inc. ($101,718) |
All Payment Transactions
289 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Rare Disease | ||||||
| 10/31/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/15/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/17/2024 | Alnylam Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $13.58 | General |
| 04/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $34.37 | General |
| 03/13/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Oncology | ||||||
| 02/02/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Rare Disease | ||||||
| 02/01/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Education | In-kind items and services | $83.99 | General |
| Category: Rare Disease | ||||||
| 11/01/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Oncology | ||||||
| 12/11/2022 | GENZYME CORPORATION | CABLIVI (Biological), ENJAYMO | Food and Beverage | In-kind items and services | $80.89 | General |
| Category: Hematology | ||||||
| 10/09/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Oncology | ||||||
| 08/10/2022 | GENZYME CORPORATION | ENJAYMO (Biological) | Consulting Fee | Cash or cash equivalent | $2,416.00 | General |
| Category: Hematology | ||||||
| 07/08/2022 | ARGENX US, INC. | — | Consulting Fee | Cash or cash equivalent | $4,950.00 | General |
| 07/08/2022 | ARGENX US, INC. | — | Travel and Lodging | Cash or cash equivalent | $123.00 | General |
| 07/08/2022 | ARGENX US, INC. | — | Food and Beverage | Cash or cash equivalent | $75.00 | General |
| 06/25/2022 | ARGENX US, INC. | — | Travel and Lodging | In-kind items and services | $342.20 | General |
| 06/25/2022 | ARGENX US, INC. | — | Travel and Lodging | In-kind items and services | $336.55 | General |
| 06/25/2022 | ARGENX US, INC. | — | Travel and Lodging | In-kind items and services | $330.36 | General |
| 06/25/2022 | ARGENX US, INC. | — | Food and Beverage | In-kind items and services | $124.00 | General |
| 06/25/2022 | ARGENX US, INC. | — | Food and Beverage | In-kind items and services | $66.00 | General |
| 06/25/2022 | ARGENX US, INC. | — | Food and Beverage | In-kind items and services | $56.31 | General |
| 06/25/2022 | ARGENX US, INC. | — | Food and Beverage | In-kind items and services | $25.10 | General |
| 06/25/2022 | ARGENX US, INC. | — | Food and Beverage | In-kind items and services | $25.10 | General |
| 02/07/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 183 | 266 | $65,480 | $24,898 |
| 2022 | 4 | 217 | 326 | $72,555 | $27,602 |
| 2021 | 6 | 256 | 359 | $80,830 | $31,957 |
| 2020 | 6 | 179 | 225 | $51,665 | $18,536 |
Total Patients
835
Total Services
1,176
Medicare Billing
$102,993
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 98 | 160 | $32,000 | $12,049 | 37.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 53 | 74 | $19,240 | $8,006 | 41.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 32 | 32 | $14,240 | $4,844 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 113 | 195 | $39,000 | $14,743 | 37.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 34 | 52 | $13,520 | $6,296 | 46.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 31 | 31 | $13,795 | $4,336 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 39 | 48 | $6,240 | $2,226 | 35.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 104 | 176 | $35,200 | $13,666 | 38.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 57 | 80 | $20,800 | $9,505 | 45.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 30 | 30 | $13,350 | $4,682 | 35.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 31 | 38 | $4,940 | $2,041 | 41.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 17 | 17 | $5,100 | $1,567 | 30.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 17 | 18 | $1,440 | $495.99 | 34.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 60 | 72 | $18,720 | $6,877 | 36.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 55 | 86 | $17,200 | $5,782 | 33.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 13 | 13 | $5,785 | $1,823 | 31.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 11 | 11 | $3,300 | $1,241 | 37.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 13 | $2,600 | $1,225 | 47.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 14 | $1,980 | $872.34 | 44.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 16 | 16 | $2,080 | $716.80 | 34.5% |
About Dr. Iberia Sosa, MD
Dr. Iberia Sosa, MD is a Hematology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508060096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Iberia Sosa, MD has received a total of $232,058 in payments from pharmaceutical and medical device companies, with $273.52 received in 2024. These payments were reported across 289 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($162,000).
As a Medicare-enrolled provider, Sosa has provided services to 835 Medicare beneficiaries, totaling 1,176 services with total Medicare billing of $102,993. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Hematology & Oncology
- Location Philadelphia, PA
- Active Since 06/11/2007
- Last Updated 08/21/2019
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1508060096
Products in Payments
- INJECTAFER (Drug) $211,298
- ENJAYMO (Biological) $2,416
- Monoferric (Drug) $2,400
- SOLIRIS (Biological) $83.99
- CABLIVI (Biological) $80.89
- ULTOMIRIS (Biological) $51.82
- JAKAFI (Drug) $50.17
- CALQUENCE (Drug) $48.34
- MYLOTARG (Biological) $48.21
- BOSULIF (Drug) $43.18
- VONJO (Drug) $35.93
- Imbruvica (Drug) $32.88
- Vanflyta (Drug) $27.73
- Gelclair (Device) $27.36
- VPRIV (Biological) $23.93
- JEVTANA (Drug) $23.59
- Abraxane (Drug) $21.95
- FERAHEME (Drug) $21.58
- JADENU (Drug) $20.14
- SANCUSO (Drug) $17.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Philadelphia
Henry Fung, M.d, M.D
Hematology — Payments: $821,230
Hematology $821,230
Selina Luger, Md, MD
Hematology — Payments: $104,126
Hematology $104,126
Sunita Nasta, Md, MD
Hematology — Payments: $72,476
Hematology $72,476
Dr. Sanaa Rizk, Md, MD
Hematology — Payments: $63,481
Hematology $63,481
Dr. Ralph Vassallo, Md, MD
Hematology — Payments: $45,215
Hematology $45,215
Elizabeth Hexner, Md, MD
Hematology — Payments: $24,723
Hematology $24,723